Galena Biopharma Inc (GALE)-医療機器分野:企業M&A・提携分析

GlobalDataが発行した調査報告書(DATA8012963)
◆英語タイトル:Galena Biopharma Inc (GALE) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8012963
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:50
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Galena Biopharma Inc (Galena) is a biopharmaceutical company that develops and markets therapies for the treatment of unmet medical needs and advance care. The company’s pipeline products comprise NeuVax, NeuVax Present, NeuVax Hercepti, NeuVax Vadis, GALE-401 and GALE-301 folate binding protein for the treatment of breast cancer, gastric cancer, endometrial and ovarian cancer. The company develops drugs through mid-to-late-stage clinical assets led by hematology care programs. It has collaborations with cancer institutions, cancer centers and pharmaceutical and life science companies. Galena is headquartered in San Ramon, California, the US.

Galena Biopharma Inc (GALE) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Galena Biopharma Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Galena Biopharma Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Galena Biopharma Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Galena Biopharma Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Galena Biopharma Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Galena Biopharma Inc, Medical Equipment, Deal Details 10
Partnerships 10
Galena Biopharma Enters Into Co-Development Agreement With Leica Biosystems 10
Equity Offering 11
Galena Biopharma Raises Up to USD15.5 Million in Public Offering of Shares and Warrants 11
Galena Biopharma to Raise Funds in Public Offering of Shares 13
Galena Biopharma Raises USD12.6 Million in Private Placement of Shares and Warrants 14
Galena Biopharma Completes Underwriters Exercise of Over-Allotment Option of Public Offering of Shares and Warrants for USD43 Million 15
Galena Biopharma Inc – Key Competitors 17
Galena Biopharma Inc – Key Employees 18
Galena Biopharma Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
Nov 09, 2017: Galena Biopharma Reports Third Quarter 2017 Financial Results 20
Aug 14, 2017: Galena Biopharma Reports Second Quarter 2017 Financial Results 22
May 10, 2017: Galena Biopharma Reports First Quarter 2017 Financial Results 25
Mar 15, 2017: Galena Biopharma Reports Fourth Quarter and Year End 2016 Financial Results and Provides a Corporate Update 28
Nov 09, 2016: Galena Biopharma Reports Third Quarter 2016 Financial Results and Provides a Corporate Update 32
Aug 09, 2016: Galena Biopharma Reports Second Quarter 2016 Financial Results and Provides a Corporate Update 35
May 10, 2016: Galena Biopharma Reports First Quarter 2016 Financial Results and Provides a Corporate Update 38
Mar 10, 2016: Galena Biopharma Reports Fourth Quarter and Year End 2015 Financial Results and Provides a Corporate Update 41
Corporate Communications 42
Feb 21, 2017: Galena Biopharma Board of Directors Appoints Stephen F. Ghiglieri as Interim Chief Executive Officer 42
Jan 31, 2017: Galena Biopharma Announces the Resignation of its President and Chief Executive Officer and the Evaluation of Strategic Alternatives 43
Nov 03, 2016: Galena Biopharma Appoints Stephen F. Ghiglieri as Executive Vice President and Chief Financial Officer 44
Apr 26, 2016: Galena Biopharma Appoints Mary Ann Gray, Ph.D., to Its Board of Directors 45
Legal and Regulatory 47
Feb 16, 2016: Galena Biopharma Announces Proposed Settlement of Derivative Litigation 47
Other Significant Developments 48
Jul 12, 2017: Galena Biopharma Provides Corporate Update 48
Jan 05, 2017: Galena Biopharma to Provide Corporate and Clinical Update and 2017 Outlook During Presentation at Biotech Showcase 2017 49
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50

List of Tables
Galena Biopharma Inc, Medical Equipment, Key Facts, 2016 2
Galena Biopharma Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Galena Biopharma Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Galena Biopharma Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Galena Biopharma Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Galena Biopharma Inc, Deals By Market, 2011 to YTD 2017 8
Galena Biopharma Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Galena Biopharma Enters Into Co-Development Agreement With Leica Biosystems 10
Galena Biopharma Raises Up to USD15.5 Million in Public Offering of Shares and Warrants 11
Galena Biopharma to Raise Funds in Public Offering of Shares 13
Galena Biopharma Raises USD12.6 Million in Private Placement of Shares and Warrants 14
Galena Biopharma Completes Underwriters Exercise of Over-Allotment Option of Public Offering of Shares and Warrants for USD43 Million 15
Galena Biopharma Inc, Key Competitors 17
Galena Biopharma Inc, Key Employees 18
Galena Biopharma Inc, Subsidiaries 19

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Galena Biopharma Inc (GALE)-医療機器分野:企業M&A・提携分析(Galena Biopharma Inc (GALE) - Medical Equipment - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆